Cargando…

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research

OBJECTIVE: Substandard and falsified (SF) medical products are a global public health threat. The presence and spread of SF drugs negatively affect (1) patients’ safety and health outcomes, (2) national economy, (3) public trust in the healthcare system, and (4) the international fight against serio...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sweileh, Waleed M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460181/ https://www.ncbi.nlm.nih.gov/pubmed/34556126 http://dx.doi.org/10.1186/s12992-021-00766-5

Ejemplares similares

Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020)

The economic impact of substandard and falsified antimalarial medications in Nigeria
por: Beargie, Sarah M., et al.
Publicado: (2019)

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
por: Shiferie, Fisseha, et al.
Publicado: (2020)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
por: Zabala, Guillermo A, et al.
Publicado: (2022)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
por: Jackson, Kathryn D., et al.
Publicado: (2020)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
por: Rojas-Cortés, Robin
Publicado: (2020)

The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities
por: Macé, Cécile, et al.
Publicado: (2023)

Combatting Substandard and Falsified Medicines: A View from Rwanda
por: Binagwaho, Agnes, et al.
Publicado: (2013)

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
por: Yakhkind, Aleksandra, et al.
Publicado: (2022)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
por: Ferrario, Alessandra, et al.
Publicado: (2019)

Mobile apps for detecting falsified and substandard drugs: A systematic review
por: Ciapponi, Agustín, et al.
Publicado: (2021)

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
por: Kovacs, Stephanie, et al.
Publicado: (2014)

Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems
por: Chabalenge, Billy, et al.
Publicado: (2022)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
por: Wada, Yusuf Hassan, et al.
Publicado: (2022)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Pisani, Elizabeth, et al.
Publicado: (2021)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2022)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
por: Cavany, Sean, et al.
Publicado: (2023)

The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies
por: Al-Jumaili, Ali Azeez, et al.
Publicado: (2021)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
por: Kniazkov, Stanislav, et al.
Publicado: (2020)

Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies
por: Antignac, Marie, et al.
Publicado: (2019)

Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
por: Pozsgai, Kevin, et al.
Publicado: (2022)

Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines
por: Wang, Wenbo, et al.
Publicado: (2019)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
por: Akpobolokemi, Tamara, et al.
Publicado: (2022)

Retracted and Republished: A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2019)

Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden
por: Funestrand, H, et al.
Publicado: (2019)

Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea
por: Kaur, Harparkash, et al.
Publicado: (2017)

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries
por: Hauk, Cathrin, et al.
Publicado: (2021)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
por: Sylim, Patrick, et al.
Publicado: (2018)

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
por: Ahmed, Jamee, et al.
Publicado: (2022)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
por: Khurelbat, Daariimaa, et al.
Publicado: (2020)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
por: Higgins, Colleen R., et al.
Publicado: (2023)

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
por: Pisani, Elizabeth, et al.
Publicado: (2019)

Bibliometric profile of the global scientific research on autism spectrum disorders
por: Sweileh, Waleed M., et al.
Publicado: (2016)

Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
por: Wagnild, Janelle M., et al.
Publicado: (2023)

Bibliometric analysis of global scientific literature on vaccine hesitancy in peer-reviewed journals (1990–2019)
por: Sweileh, Waleed M.
Publicado: (2020)

Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
por: Kusynová, Zuzana, et al.
Publicado: (2023)

Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018)

Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches
por: Ozawa, Sachiko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3lh08edimuu454ap9v2enfukev